Madrigal Pharmaceuticals, Inc. (LON:0JXI)

Madrigal Pharmaceuticals Statistics

Total Valuation

LON:0JXI has a market cap or net worth of GBP 9.13 billion. The enterprise value is 8.55 billion.

Market Cap	9.13B
Enterprise Value	8.55B

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.71M
Shares Outstanding	n/a
Shares Change (YoY)	+6.98%
Shares Change (QoQ)	+1.24%
Owned by Insiders (%)	11.26%
Owned by Institutions (%)	69.60%
Float	11.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	186.79
PS Ratio	16.58
PB Ratio	19.62
P/TBV Ratio	19.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-39.76
EV / Sales	15.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-71.13

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.55.

Current Ratio	3.44
Quick Ratio	3.12
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-2.14
Interest Coverage	-17.56

Financial Efficiency

Return on equity (ROE) is -41.22% and return on invested capital (ROIC) is -20.57%.

Return on Equity (ROE)	-41.22%
Return on Assets (ROA)	-15.78%
Return on Invested Capital (ROIC)	-20.57%
Return on Capital Employed (ROCE)	-31.67%
Revenue Per Employee	1.04M
Profits Per Employee	-407,371
Employee Count	528
Asset Turnover	0.61
Inventory Turnover	0.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.36% in the last 52 weeks. The beta is -0.76, so LON:0JXI's price volatility has been lower than the market average.

Beta (5Y)	-0.76
52-Week Price Change	+66.36%
50-Day Moving Average	445.93
200-Day Moving Average	355.45
Relative Strength Index (RSI)	72.52
Average Volume (20 Days)	73

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.37

Income Statement

In the last 12 months, LON:0JXI had revenue of GBP 550.99 million and -215.09 million in losses. Loss per share was -9.70.

Revenue	550.99M
Gross Profit	524.85M
Operating Income	-228.75M
Pretax Income	-215.09M
Net Income	-215.09M
EBITDA	-227.65M
EBIT	-228.75M
Loss Per Share	-9.70

Balance Sheet

The company has 825.59 million in cash and 257.70 million in debt, giving a net cash position of 567.88 million.

Cash & Cash Equivalents	825.59M
Total Debt	257.70M
Net Cash	567.88M
Net Cash Per Share	n/a
Equity (Book Value)	465.51M
Book Value Per Share	20.50
Working Capital	710.67M

Cash Flow

In the last 12 months, operating cash flow was -119.46 million and capital expenditures -782,625, giving a free cash flow of -120.24 million.

Operating Cash Flow	-119.46M
Capital Expenditures	-782,625
Free Cash Flow	-120.24M
FCF Per Share	n/a

Margins

Gross margin is 95.25%, with operating and profit margins of -41.52% and -39.04%.

Gross Margin	95.25%
Operating Margin	-41.52%
Pretax Margin	-39.04%
Profit Margin	-39.04%
EBITDA Margin	-41.32%
EBIT Margin	-41.52%
FCF Margin	n/a

Dividends & Yields

LON:0JXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.98%
Shareholder Yield	-6.98%
Earnings Yield	-2.36%
FCF Yield	-1.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0JXI has an Altman Z-Score of 4.3 and a Piotroski F-Score of 2.

Altman Z-Score	4.3
Piotroski F-Score	2